Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Globus Medical (NYSE:GMED), a leading musculoskeletal solutions company, has announced it will release its financial results for the third quarter ended September 30, 2024, after the market close on Tuesday, November 5, 2024. The company will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time on the same day.
Investors can access the conference call via webcast on the Investors page of Globus Medical's website. For telephone participation, registration is required in advance. Upon registration, participants will receive a confirmation email with dial-in details. An audio archive of the call will be available on the company's website after the event.
Globus Medical (NYSE:GMED), una delle aziende leader nelle soluzioni muscoloscheletriche, ha annunciato che rilascerà i suoi risultati finanziari per il terzo trimestre chiuso il 30 settembre 2024, dopo la chiusura del mercato di martedì 5 novembre 2024. L'azienda terrà una teleconferenza per discutere delle sue performance con la comunità degli investitori alle 16:30 ora orientale dello stesso giorno.
Gli investitori possono partecipare alla telefonata tramite webcast nella pagina dedicata agli Investitori del sito web di Globus Medical. Per partecipare telefonicamente, è necessaria la registrazione anticipata. Dopo la registrazione, i partecipanti riceveranno un'email di conferma con i dettagli per la chiamata. Un archivio audio della chiamata sarà disponibile sul sito web dell'azienda dopo l'evento.
Globus Medical (NYSE:GMED), una empresa líder en soluciones musculoesqueléticas, ha anunciado que publicará sus resultados financieros para el tercer trimestre que finalizó el 30 de septiembre de 2024, después del cierre del mercado el martes 5 de noviembre de 2024. La empresa llevará a cabo una teleconferencia para discutir su desempeño con la comunidad de inversionistas a las 4:30 p.m. hora del Este del mismo día.
Los inversionistas pueden acceder a la llamada de la conferencia a través de una transmisión en vivo en la página de Inversionistas del sitio web de Globus Medical. Para participar por teléfono, se requiere registro previo. Al registrarse, los participantes recibirán un correo electrónico de confirmación con los detalles de acceso. Un archivo de audio de la llamada estará disponible en el sitio web de la empresa después del evento.
Globus Medical (NYSE:GMED), 선도적인 근골격계 솔루션 회사는 2024년 9월 30일 종료된 3분기 재무 결과를 2024년 11월 5일 화요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 투자 커뮤니티와 성과에 대해 논의하기 위한 전화 회의를 개최합니다.
투자자들은 Globus Medical 웹사이트의 투자자 페이지를 통해 웨비나에 접속할 수 있습니다. 전화 참여를 원할 경우 사전 등록이 필요합니다. 등록 후 참가자는 다이얼인 세부정보가 포함된 확인 이메일을 받게 됩니다. 회의의 오디오 아카이브는 이벤트 후 회사 웹사이트에서 제공됩니다.
Globus Medical (NYSE:GMED), une entreprise leader dans les solutions musculo-squelettiques, a annoncé qu'elle publiera ses résultats financiers pour le troisième trimestre clos le 30 septembre 2024, après la fermeture du marché le mardi 5 novembre 2024. L'entreprise tiendra une téléconférence pour discuter de ses performances avec la communauté des investisseurs à 16h30, heure de l'Est le même jour.
Les investisseurs peuvent accéder à l'appel de conférence via un webinaire sur la page Investisseurs du site web de Globus Medical. Pour participer par téléphone, une inscription préalable est requise. Après l'inscription, les participants recevront un e-mail de confirmation contenant les détails de connexion. Un archive audio de l'appel sera disponible sur le site de l'entreprise après l'événement.
Globus Medical (NYSE:GMED), ein führendes Unternehmen für muskuloskelettale Lösungen, hat angekündigt, dass es nach Börsenschluss am Dienstag, dem 5. November 2024 seine Finanzergebnisse für das dritte Quartal zum 30. September 2024 veröffentlichen wird. Das Unternehmen wird am gleichen Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um seine Leistungen mit der Investment-Community zu besprechen.
Investoren können die Telefonkonferenz über einen Webcast auf der Investoren-Seite der Website von Globus Medical verfolgen. Für die telefonische Teilnahme ist eine vorherige Registrierung erforderlich. Nach der Registrierung erhalten die Teilnehmer eine Bestätigungs-E-Mail mit den Einwahldaten. Ein Audio-Archiv der Konferenz wird nach der Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call on the Investors page of the Globus Medical website.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive business and our ability to successfully integrate and to achieve anticipated synergies with the integration, health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changes and applicable laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contacts:
Investors:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com
Media:
Moran Chavez
Senior Director, Corporate Affairs
Phone: (619) 318-7681
Email: media@globusmedical.com
FAQ
When will Globus Medical (GMED) release its Q3 2024 earnings?
How can investors participate in Globus Medical's (GMED) Q3 2024 earnings call?
Where can I find Globus Medical's (GMED) Q3 2024 earnings release?
Will there be an audio archive of Globus Medical's (GMED) Q3 2024 earnings call?
